Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Novocure Ltd Ord Sh
(NQ:
NVCR
)
17.09
+0.23 (+1.36%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Novocure Ltd Ord Sh
< Previous
1
2
3
4
5
6
7
8
9
...
17
18
Next >
Novocure Announces FDA Acceptance of the PMA Application for TTFields Therapy in Non-Small Cell Lung Cancer
January 18, 2024
From
Novocure
Via
Business Wire
Why WD-40 Shares Are Trading Higher By Over 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
January 10, 2024
Shares of WD-40 Company (NASDAQ: WDFC) rose sharply during Wednesday’s session after the company reported better-than-expected first-quarter results.
Via
Benzinga
Veradigm, Aehr Test Systems, Saratoga Investment And Other Big Stocks Moving Lower On Wednesday
January 10, 2024
U.S. stocks traded slightly higher, with the Dow Jones index gaining over 20 points on Wednesday. Shares of Veradigm Inc. (NASDAQ: MDRX) shares fell sharply during Wednesday’s session.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Is Novocure Stock a Buy?
November 03, 2023
The stock isn't far from its 52-week low.
Via
The Motley Fool
Novocure Announces Last Patient Enrolled in Phase 3 TRIDENT Trial in Newly Diagnosed Glioblastoma
January 09, 2024
From
Novocure
Via
Business Wire
Novocure Announces Preliminary Full Year and Fourth Quarter 2023 Net Revenues and Provides Company Update
January 08, 2024
From
Novocure
Via
Business Wire
Novocure Appoints Dr. Nicolas Leupin as Chief Medical Officer
January 04, 2024
From
Novocure
Via
Business Wire
Why Novocure Stock Fell 24.4% This Week
August 31, 2023
Novocure announced a disappointing outcome from a phase 3 clinical trial for a key cancer treatment.
Via
The Motley Fool
Novocure to Participate in 42nd Annual J.P. Morgan Healthcare Conference
December 27, 2023
From
Novocure
Via
Business Wire
7 Nasdaq Stocks Down 59% Set to Soar at Least 141%
December 12, 2023
Wall Street always think companies are high-growth potential stocks but a little circumspection is required before buying
Via
InvestorPlace
FCEL Stock Alert: FuelCell Energy Announces AI Deal With IBM
November 28, 2023
FuelCell Energy stock is climbing higher on Tuesday as investors in FCEL celebrate the company signing a deal with IBM!
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Novocure Layoffs 2023: What to Know About the Latest NVCR Job Cuts
November 28, 2023
Novocure layoffs are coming for 13% of the company's workers as it seeks to reduce its headcount by 200 people to reduce costs.
Via
InvestorPlace
Topics
Workforce
Exposures
Layoff
Novocure Announces Portfolio Prioritization and Strategic Restructuring Plan Focused on Near-term Growth Drivers and an Accelerated Path to Profitability
November 28, 2023
From
Novocure
Via
Business Wire
Novocure to Participate in 35th Annual Piper Sandler Healthcare Conference
November 21, 2023
From
Novocure
Via
Business Wire
Novocure Announces Presentations on Tumor Treating Fields Therapy, Including New Clinical Data and Real-World Evidence, at 2023 Society for Neuro-Oncology Annual Meeting
November 10, 2023
From
Novocure
Via
Business Wire
Why Novocure Stock Was Sick Today
October 26, 2023
Investors weren't particularly pleased with the company's third-quarter performance.
Via
The Motley Fool
NovoCure (NVCR) Q3 2023 Earnings Call Transcript
October 26, 2023
NVCR earnings call for the period ending September 30, 2023.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Novocure Reports Third Quarter 2023 Financial Results
October 26, 2023
From
Novocure
Via
Business Wire
Novocure Announces Presence at European Society for Medical Oncology (ESMO) Congress 2023
October 15, 2023
From
Novocure
Via
Business Wire
Novocure and Stanford School of Medicine to Establish Tumor Treating Fields Research Program
October 12, 2023
From
Novocure
Via
Business Wire
NovoCure Limited (NASDAQ:NVCR) Long Term Shareholder Notice: Investigation of Potential Wrongdoing
October 10, 2023
San Diego, CA -- (SBWIRE) -- 10/10/2023 -- An investigation was announced for investors in shares of NovoCure Limited (NASDAQ:NVCR) concerning potential breaches of fiduciary duties by certain...
Via
SBWire
10 Health Care Stocks Whale Activity In Today's Session
October 05, 2023
Via
Benzinga
Novocure to Report Third Quarter 2023 Financial Results
October 02, 2023
From
Novocure
Via
Business Wire
Novocure Announces Presence at American Society for Radiation Oncology (ASTRO) 2023 Annual Meeting
September 29, 2023
From
Novocure
Via
Business Wire
Stocks That Hit 52-Week Lows On Friday
September 29, 2023
Friday's session saw 112 companies set new 52-week lows.
Via
Benzinga
3 Things About NovoCure That Smart Investors Know
September 19, 2023
Its cancer-treating device is struggling to find its market.
Via
The Motley Fool
Novocure Highlights Use of Tumor Treating Fields Therapy in Treatment of Non-Small Cell Lung Cancer at 2023 World Conference on Lung Cancer
September 08, 2023
From
Novocure
Via
Business Wire
3 Healthcare Stocks to Sell in September Before They Crash & Burn
September 06, 2023
The prognosis for these healthcare stocks isn't optimistic so plan to sell them this month before they get worse.
Via
InvestorPlace
Down 31% in 1 Day, What's Next for NovoCure Stock?
September 04, 2023
It's entering a risky period, but it could persevere.
Via
The Motley Fool
Is NovoCure's Stock Headed for a Free Fall?
August 31, 2023
It can be hard to find a reason to remain bullish on NovoCure.
Via
The Motley Fool
< Previous
1
2
3
4
5
6
7
8
9
...
17
18
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.